Contruent
Contruent provides a cloud-based platform for lifecycle cost management tailored to engineering and construction firms. Its software enables organizations to plan, manage, and control large, complex capital programs with greater efficiency and transparency. Serving more than 250 blue-chip clients worldwide, the company is a trusted partner in delivering cost certainty and improved decision-making for major projects.
Investment Details
Select Industry Investments
casavi
- Invested
- December 2020
- Status
- Exited
- Industry
- Software & IT
- Region
- Europe
- Business Unit
- Riverside Acceleration Capital
- Strategy
- Flexible Capital
Platform for all areas of application related to digital management of real estate
View Profile
Doctor.com
- Invested
- September 2016
- Status
- Exited
- Industry
- Software & IT
- Region
- North America
- Business Unit
- Riverside Acceleration Capital
- Strategy
- Flexible Capital
Connects patients, providers and healthcare enterprise with a single platform. Online reputation management for doctors.
View Profile
Trustwell
- Invested
- February 2022
- Status
- Active
- Industry
- Software & IT
- Region
- North America
- Business Unit
- Riverside Micro-Cap
- Strategy
- Private Equity
Provider of nutritional analysis, labeling compliance, and product formulation software
View Profile
BlueFletch
- Invested
- July 2025
- Status
- Active
- Industry
- Software & IT
- Region
- North America
- Business Unit
- Riverside Acceleration Capital
- Strategy
- Flexible Capital
Provider of security management software
View Profile
CreditLogic
- Invested
- July 2024
- Status
- Active
- Industry
- Software & IT
- Region
- Europe
- Business Unit
- Riverside Acceleration Capital
- Strategy
- Flexible Capital
Provider of SaaS-based data management and decisioning platform
View Profile
Partium
- Invested
- June 2024
- Status
- Active
- Industry
- Software & IT
- Region
- North America
- Business Unit
- Riverside Acceleration Capital
- Strategy
- Flexible Capital
Parts identification and management platform
View Profile
